幸存者 (BIRC5):癌症治疗中的影响
Giuseppe Siragusa1, Laura Tomasello1, Carla Giordano1
1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Italy.
Life sciences
|June 7, 2024
概括
抑制亡的蛋白质Survivin对于成年干细胞和癌症进展至关重要. 向生存提供了一个有希望的策略来治疗各种癌症,如瘤,瘤和白血病.
科学领域:
- * 分子生物学 * 分子生物学
- * 癌症生物学 癌症生物学
- * * 干细胞生物学
背景情况:
- * 亡蛋白抑制剂 (IAP) 最初是因为它们在预防编程细胞死亡中的作用而被发现的.
- * IAP成员Survivin对于细胞周期调节,染色体分离和成年干细胞维护至关重要.
- *异常生存表达在癌症中很常见,促进瘤生长和存活.
研究的目的:
- * 探索针对Survivin作为抗癌疗法的理由.
- * 检查Survivin在各种癌症类型中的作用,包括癌瘤,瘤和白血病.
- * 通过癌症信号通路,遗传变异 (SNP) 和微RNA (miRNA) 审查Survivin的调节.
主要方法:
- *对Survivin的功能和治疗向的现有文献的审查.
- * 对Survivin参与癌症支持生存信号的分析.
- * 对幸存单核酸多态 (SNPs) 和瘤发生之间的关系的检查.
- *通过miRNAs对生存调节的研究.
- *不同抑制策略下的细胞生长,克隆性潜力和细胞亡的比较.
主要成果:
- * 幸存者过度表达与癌细胞中增强的细胞增殖,存活率和对亡的抵抗力有关.
- * 幸存者在成人干细胞维护中的作用表明潜在的点毒性与治疗抑制.
- * 幸存者基因中的遗传变异 (SNP) 可能会影响癌症风险和进展.
- *miRNAs在调节Survivin表达和功能方面发挥着重要作用.
- *正在探索各种策略,包括基因表达和蛋白质活性调节,以抑制Survivin.
结论:
- *因其在癌细胞存活和增殖中的关键作用,Survivin是一种经过验证的治疗标.
- *了解Survivin通过信号通路,遗传学和miRNAs的复杂调节对于有效的治疗开发至关重要.
- * 针对基因表达或蛋白质活性,抑制Survivin的各种方法对癌症治疗具有前途.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:31The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K